CAR-T cell therapy is a type of treatment for certain blood cancers that involves modifying a patient's T-cells in a lab by adding a gene for a chimeric antigen receptor (CAR). This enables the modified T-cells to attach to a specific cancer cell antigen and work to eliminate the cancer. CAR-T cell therapy is typically used after other cancer treatments have failed and may require multiple modified T-cells.
Fundamental, Research
Biopharma: The CAR-T Party is Getting Crowded
28 July 2022
Summary
Want to learn more? Download the Report.
Solutions
Fundamental Equity Research
Gain a comprehensive view of global themes, industries, and companies.
Public Policy & Legal Research
Identify opportunity and risk driven by public policy and the courts.